TY - JOUR
T1 - CT perfusion during delayed cerebral ischemia after subarachnoid hemorrhage
T2 - distinction between reversible ischemia and ischemia progressing to infarction
AU - Cremers, Charlotte H P
AU - Vos, Pieter C.
AU - van der Schaaf, Irene C.
AU - Velthuis, BK
AU - Vergouwen, Mervyn D I
AU - Rinkel, Gabriel J E
AU - Dankbaar, Jan Willem
PY - 2015/6/2
Y1 - 2015/6/2
N2 - Introduction: Delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (aSAH) can be reversible or progress to cerebral infarction. In patients with a deterioration clinically diagnosed as DCI, we investigated whether CT perfusion (CTP) can distinguish between reversible ischemia and ischemia progressing to cerebral infarction. Methods: From a prospectively collected series of aSAH patients, we included those with DCI, CTP on the day of clinical deterioration, and follow-up imaging. In qualitative CTP analyses (visual assessment), we calculated positive and negative predictive value (PPV and NPV) with 95 % confidence intervals (95%CI) of a perfusion deficit for infarction on follow-up imaging. In quantitative analyses, we compared perfusion values of the least perfused brain tissue between patients with and without infarction by using receiver-operator characteristic curves and calculated a threshold value with PPV and NPV for the perfusion parameter with the highest area under the curve. Results: In qualitative analyses of 33 included patients, 15 of 17 patients (88 %) with and 6 of 16 patients (38 %) without infarction on follow-up imaging had a perfusion deficit during clinical deterioration (p = 0.002). Presence of a perfusion deficit had a PPV of 71 % (95%CI: 48–89 %) and NPV of 83 % (95%CI: 52–98 %) for infarction on follow-up. Quantitative analyses showed that an absolute minimal cerebral blood flow (CBF) threshold of 17.7 mL/100 g/min had a PPV of 63 % (95%CI: 41–81 %) and a NPV of 78 % (95%CI: 40–97 %) for infarction. Conclusions: CTP may differ between patients with DCI who develop infarction and those who do not. For this purpose, qualitative evaluation may perform marginally better than quantitative evaluation.
AB - Introduction: Delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (aSAH) can be reversible or progress to cerebral infarction. In patients with a deterioration clinically diagnosed as DCI, we investigated whether CT perfusion (CTP) can distinguish between reversible ischemia and ischemia progressing to cerebral infarction. Methods: From a prospectively collected series of aSAH patients, we included those with DCI, CTP on the day of clinical deterioration, and follow-up imaging. In qualitative CTP analyses (visual assessment), we calculated positive and negative predictive value (PPV and NPV) with 95 % confidence intervals (95%CI) of a perfusion deficit for infarction on follow-up imaging. In quantitative analyses, we compared perfusion values of the least perfused brain tissue between patients with and without infarction by using receiver-operator characteristic curves and calculated a threshold value with PPV and NPV for the perfusion parameter with the highest area under the curve. Results: In qualitative analyses of 33 included patients, 15 of 17 patients (88 %) with and 6 of 16 patients (38 %) without infarction on follow-up imaging had a perfusion deficit during clinical deterioration (p = 0.002). Presence of a perfusion deficit had a PPV of 71 % (95%CI: 48–89 %) and NPV of 83 % (95%CI: 52–98 %) for infarction on follow-up. Quantitative analyses showed that an absolute minimal cerebral blood flow (CBF) threshold of 17.7 mL/100 g/min had a PPV of 63 % (95%CI: 41–81 %) and a NPV of 78 % (95%CI: 40–97 %) for infarction. Conclusions: CTP may differ between patients with DCI who develop infarction and those who do not. For this purpose, qualitative evaluation may perform marginally better than quantitative evaluation.
KW - CT perfusion
KW - Delayed cerebral ischemia
KW - Subarachnoid hemorrhage
UR - http://www.scopus.com/inward/record.url?scp=84930320567&partnerID=8YFLogxK
U2 - 10.1007/s00234-015-1543-3
DO - 10.1007/s00234-015-1543-3
M3 - Article
C2 - 26032925
AN - SCOPUS:84930320567
SN - 0028-3940
VL - 57
SP - 897
EP - 902
JO - Neuroradiology
JF - Neuroradiology
IS - 9
ER -